D-0166-2021 Class I Terminated
FDA drug recall D-0166-2021 was initiated by Torrent Pharma Inc on Nov 25, 2020 and is designated Class I. Reason for recall: Failed Dissolution Specifications The recall status is terminated (terminated Dec 28, 2022). Affected quantity: 2496 Bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Dec 9, 2020
- Initiation Date
- Nov 25, 2020
- Termination Date
- Dec 28, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2496 Bottles
Product description
Anagrelide Capsules, USP 1 mg, 100 capsules, Rx only, Manufactured in India for: Torrent Pharma Inc., Basking Ridge, NJ 07920 NDC 13668-462-01
Reason for recall
Failed Dissolution Specifications
Distribution pattern
Nationwide USA and Puerto Rico
Code information
Batch BFD1G001, exp 12/2021
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0166-2021
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026